414 related articles for article (PubMed ID: 31766164)
1. The Importance of HLA Assessment in "Off-the-Shelf" Allogeneic Mesenchymal Stem Cells Based-Therapies.
Kot M; Baj-Krzyworzeka M; Szatanek R; Musiał-Wysocka A; Suda-Szczurek M; Majka M
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31766164
[TBL] [Abstract][Full Text] [Related]
2. Challenges in allogeneic mesenchymal stem cell-mediated cardiac repair.
Dhingra S; Huang XP; Li RK
Trends Cardiovasc Med; 2010 Nov; 20(8):263-8. PubMed ID: 22433652
[TBL] [Abstract][Full Text] [Related]
3. Comparison of allogeneic vs autologous bone marrow–derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial.
Hare JM; Fishman JE; Gerstenblith G; DiFede Velazquez DL; Zambrano JP; Suncion VY; Tracy M; Ghersin E; Johnston PV; Brinker JA; Breton E; Davis-Sproul J; Schulman IH; Byrnes J; Mendizabal AM; Lowery MH; Rouy D; Altman P; Wong Po Foo C; Ruiz P; Amador A; Da Silva J; McNiece IK; Heldman AW; George R; Lardo A
JAMA; 2012 Dec; 308(22):2369-79. PubMed ID: 23117550
[TBL] [Abstract][Full Text] [Related]
4. Mesenchymal stem cells: immune evasive, not immune privileged.
Ankrum JA; Ong JF; Karp JM
Nat Biotechnol; 2014 Mar; 32(3):252-60. PubMed ID: 24561556
[TBL] [Abstract][Full Text] [Related]
5. The Latest Developments in Immunomodulation of Mesenchymal Stem Cells in the Treatment of Intrauterine Adhesions, Both Allogeneic and Autologous.
Chen JM; Huang QY; Zhao YX; Chen WH; Lin S; Shi QY
Front Immunol; 2021; 12():785717. PubMed ID: 34868069
[TBL] [Abstract][Full Text] [Related]
6. Allogeneic Mesenchymal Stromal Cells (MSCs) are of Comparable Efficacy to Syngeneic MSCs for Therapeutic Revascularization in C57BKSdb/db Mice Despite the Induction of Alloantibody.
Liew A; Baustian C; Thomas D; Vaughan E; Sanz-Nogués C; Creane M; Chen X; Alagesan S; Owens P; Horan J; Dockery P; Griffin MD; Duffy A; O'Brien T
Cell Transplant; 2018 Aug; 27(8):1210-1221. PubMed ID: 30016879
[TBL] [Abstract][Full Text] [Related]
7. Cotransplantation of mesenchymal stem cells might prevent death from graft-versus-host disease (GVHD) without abrogating graft-versus-tumor effects after HLA-mismatched allogeneic transplantation following nonmyeloablative conditioning.
Baron F; Lechanteur C; Willems E; Bruck F; Baudoux E; Seidel L; Vanbellinghen JF; Hafraoui K; Lejeune M; Gothot A; Fillet G; Beguin Y
Biol Blood Marrow Transplant; 2010 Jun; 16(6):838-47. PubMed ID: 20109568
[TBL] [Abstract][Full Text] [Related]
8. Concise review: combining human leukocyte antigen G and mesenchymal stem cells for immunosuppressant biotherapy.
Naji A; Rouas-Freiss N; Durrbach A; Carosella ED; Sensébé L; Deschaseaux F
Stem Cells; 2013 Nov; 31(11):2296-303. PubMed ID: 23922260
[TBL] [Abstract][Full Text] [Related]
9. Safety of Allogeneic Mesenchymal Stem Cell Seeding of NeuraGen Nerve Guides in a Rabbit Model.
Bedar M; van Wijnen AJ; Shin AY
Tissue Eng Part C Methods; 2023 Feb; 29(2):43-53. PubMed ID: 36680753
[TBL] [Abstract][Full Text] [Related]
10. Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+CD25highFOXP3+ regulatory T cells.
Selmani Z; Naji A; Zidi I; Favier B; Gaiffe E; Obert L; Borg C; Saas P; Tiberghien P; Rouas-Freiss N; Carosella ED; Deschaseaux F
Stem Cells; 2008 Jan; 26(1):212-22. PubMed ID: 17932417
[TBL] [Abstract][Full Text] [Related]
11. Autologous, allogeneic, induced pluripotent stem cell or a combination stem cell therapy? Where are we headed in cartilage repair and why: a concise review.
Vonk LA; de Windt TS; Slaper-Cortenbach IC; Saris DB
Stem Cell Res Ther; 2015 May; 6(1):94. PubMed ID: 25976213
[TBL] [Abstract][Full Text] [Related]
12. The potential use of mesenchymal stem cells in hematopoietic stem cell transplantation.
Kim EJ; Kim N; Cho SG
Exp Mol Med; 2013 Jan; 45(1):e2. PubMed ID: 23306700
[TBL] [Abstract][Full Text] [Related]
13. Human leukocyte antigen selected allogeneic mesenchymal stromal cell therapy in renal transplantation: The Neptune study, a phase I single-center study.
Dreyer GJ; Groeneweg KE; Heidt S; Roelen DL; van Pel M; Roelofs H; Huurman VAL; Bajema IM; Moes DJAR; Fibbe WE; Claas FHJ; van Kooten C; Rabelink RJ; de Fijter JW; Reinders MEJ
Am J Transplant; 2020 Oct; 20(10):2905-2915. PubMed ID: 32277568
[TBL] [Abstract][Full Text] [Related]
14. Allo-reactivity of mesenchymal stem cells in rhesus macaques is dose and haplotype dependent and limits durable cell engraftment in vivo.
Isakova IA; Lanclos C; Bruhn J; Kuroda MJ; Baker KC; Krishnappa V; Phinney DG
PLoS One; 2014; 9(1):e87238. PubMed ID: 24489878
[TBL] [Abstract][Full Text] [Related]
15. Characterization of EGFP-labeled mesenchymal stem cells and redistribution of allogeneic cells after subcutaneous implantation.
Duan X; Yang L; Dong S; Xin R; Chen G; Guo L
Arch Orthop Trauma Surg; 2008 Jul; 128(7):751-9. PubMed ID: 18265994
[TBL] [Abstract][Full Text] [Related]
16. Although pig allogeneic mesenchymal stem cells are not immunogenic in vitro, intracardiac injection elicits an immune response in vivo.
Poncelet AJ; Vercruysse J; Saliez A; Gianello P
Transplantation; 2007 Mar; 83(6):783-90. PubMed ID: 17414713
[TBL] [Abstract][Full Text] [Related]
17. Mesenchymal Stem Cells in Systemic Sclerosis: Allogenic or Autologous Approaches for Therapeutic Use?
Rozier P; Maria A; Goulabchand R; Jorgensen C; Guilpain P; Noël D
Front Immunol; 2018; 9():2938. PubMed ID: 30619298
[TBL] [Abstract][Full Text] [Related]
18. Human embryonic stem cell-derived mesenchymal stroma cells (hES-MSCs) engraft in vivo and support hematopoiesis without suppressing immune function: implications for off-the shelf ES-MSC therapies.
Li O; Tormin A; Sundberg B; Hyllner J; Le Blanc K; Scheding S
PLoS One; 2013; 8(1):e55319. PubMed ID: 23383153
[TBL] [Abstract][Full Text] [Related]
19. Immunomodulation effect of mesenchymal stem cells in islet transplantation.
Shrestha M; Nguyen TT; Park J; Choi JU; Yook S; Jeong JH
Biomed Pharmacother; 2021 Oct; 142():112042. PubMed ID: 34403963
[TBL] [Abstract][Full Text] [Related]
20. Immunosuppressive effects of mesenchymal stem cells: involvement of HLA-G.
Nasef A; Mathieu N; Chapel A; Frick J; François S; Mazurier C; Boutarfa A; Bouchet S; Gorin NC; Thierry D; Fouillard L
Transplantation; 2007 Jul; 84(2):231-7. PubMed ID: 17667815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
